The stratification algorithm we use combines diagnosis of MCI, carriage of the apolipoprotein E (APOE) ε4 allele, family history of dementia in a first-degree relative, advancing age (treated as continuous variable), sex and where available cognitive function and AD biomarkers in plasma. The gene discussed is APOE; the disease is dementia.